Navigation Links
Custom Conjugation Services from SoluLink

ProductsCustom Conjugation Services from SoluLink
Company SoluLink
Item Custom Conjugation Services
Price 
Description Conjugation services for Antibodies, Proteins, Oligos, Peptides, Beads, bioconjugation, antibody-oligonucleotide, LNA peptide, LNA protein, LNA antibody, HRP, Alkaline phosphatase, phycoerythrin, FITC, antibody enzyme conjugate
Info SoluLinkSoluLink
Solulink, Incorporated
9853 Pacific Heights Blvd. Suite H,
San Diego, California 92121

Call SoluLink to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-858-866-8871
Customer Service: 858.625.0670
Fax Number: 858.625.0770
Web Site: http://www.solulink.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Peptide Design and Custom Synthesis from Global Peptide Services, LLC.
2. Custom Arraying Service from Whatman, Inc
3. Custom 2-OMe RNA Aptamer Microarray from LC Sciences
4. Custom DNA Aptamer Microarray from LC Sciences
5. Custom 2-F RNA Aptamer Microarray from LC Sciences
6. Custom Peptide Microarray - Comprehensive Service from LC Sciences
7. Custom DNA Microarray from LC Sciences
8. Custom Antibody Production Services from Aves Labs, Inc.
9. EvoQuest ™ Custom Laboratory Services from Invitrogen
10. Custom Processing Service from Whatman, Inc
11. Custom Phosphopeptide Microarray from LC Sciences
Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 2Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 3Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 4WuXi PharmaTech Selects Labcyte POD(TM) 810 Platform for High-Throughput Screening 2